Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
BELLUS Health Inc | BLU | Toronto | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
19.48 | 19.48 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 19.10 - 19.90 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | $ 19.48 | CAD |
BELLUS Health Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 2.47B | - | - | - | -9,838.50 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
BELLUS Health News
Date | Time | Source | News Article |
---|---|---|---|
6/28/2023 | 09:59 | PR Newswire (Canada) | Annonce boursière - Réservée aux médias et aux investisseurs.. |
6/28/2023 | 09:57 | PR Newswire (Canada) | Stock-exchange announcement - For media and investors only -.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLU Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 19.42 | 19.90 | 19.10 | 19.55 | 48,610 | 0.06 | 0.31% |
3 Years | 4.66 | 19.90 | 3.32 | 10.89 | 111,038 | 14.82 | 318.03% |
5 Years | 1.40 | 19.90 | 1.31 | 7.83 | 139,006 | 18.08 | 1,291.43% |
BELLUS Health Description
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has... |